Home › Companies › Clover Health Investments, Corp. › 2025-2026

Clover Health Investments, Corp. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Clover Health Investments, Corp.’s Form 8-K, filed 2026-06-12 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 5Ballot items
  • 163Asset managers
  • 838Fund votes
  • 2026-06-10Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Clover Health Investments, Corp. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Clover Health Investments, Corp.

These tallies are Clover Health Investments, Corp.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Clover Health Investments, Corp. — official shareholder meeting results, meeting held 2026-06-10
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Demetrios L. Kouzoukas 1,003,131,251---- 11,409,888177,790,033 Majority: yes
Elect Director: Andrew Toy 1,011,117,814---- 3,423,325177,790,033 Majority: yes
Elect Director: Thomas L. Tran 996,918,879---- 17,622,260177,790,033 Majority: yes
Proposal 2: Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2025 1,003,065,4029,811,8251,663,812 --177,790,033 Majority: yes
Proposal 3: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 1,188,467,6632,471,6061,391,903 ---- Majority: yes

Source: Clover Health Investments, Corp., Form 8-K, filed with the SEC on 2026-06-12 — read the filing on EDGAR.

How asset managers voted at the Clover Health Investments, Corp. 2025-2026 meeting

Each item below shows how the 163 asset managers that disclosed a Clover Health Investments, Corp. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 1,003,065,402AGAINST: 9,811,825

Clover Health Investments, Corp.’s own tally for this item (“Proposal 2: Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2025”): 1,003,065,402 for, 9,811,825 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 163 asset managers below cast 99% of the shares they voted on this item FOR (66,907,046 for, 938,536 against).

FOR 99%
FOR: 66,907,046 (98.6%)AGAINST: 938,536 (1.4%)ABSTAIN: 4,208 (0.0%)
Largest asset managers voting on “Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025.” at Clover Health Investments, Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard23,876,046101 170For
BlackRock13,709,2330 00For
Charles Schwab10,615,9150 00For
State Street4,028,5950 00For
Northern Trust2,273,6280 00For
GEODE CAPITAL MANAGEMENT, LLC1,755,4220 00For
Fidelity1,183,3440 00For
Equitable832,2930 00For
Nuveen822,6250 00For
TIAA733,9240 00For
GMT CAPITAL CORP701,6000 00For
UBS0562,736 00Against
T. Rowe Price546,2030 00For
MELLON INVESTMENTS Corp540,8960 00For
Lincoln Financial526,0540 00For
AllianceBernstein398,8000 00For
Global X335,6780 00For
Goldman Sachs283,1150 00For
Dimensional251,3580 00For
FRANKLIN ADVISERS INC247,8540 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM226,4080 00For
Invesco220,3380 00For
Allianz0198,166 00Against
JPMorgan145,4080 00For
Pacific Life138,1830 00For

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

2. ELECTION OF DIRECTORS: Andrew Toy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 1,011,117,814WITHHELD: 3,423,325

Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Andrew Toy”): 1,011,117,814 for, 3,423,325 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 44 asset managers below cast 100% of the shares they voted on this item FOR (33,251,658 for, 0 against).

FOR 99.4%
FOR: 33,251,658 (99.4%)ABSTAIN: 198,444 (0.6%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Andrew Toy” at Clover Health Investments, Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,478,8850 37,7960For
Charles Schwab5,306,4210 00For
BlackRock2,548,8260 00For
Fidelity1,175,0870 00For
Equitable832,2930 00For
TIAA733,9240 00For
Lincoln Financial526,0540 00For
Global X335,6780 00For
Northern Trust182,9890 00For
State Street159,7750 290For
JPMorgan145,4080 00For
Pacific Life138,1830 00For
Lazard100,9170 00For
Dimensional00 79,5730Abstain
Bridge Builder Trust78,3410 00For
SEI60,2000 00For
DWS56,9760 00For
ProShares45,5150 00For
AIG/SunAmerica45,3160 00For
T. Rowe Price40,7350 00For
Jackson National00 39,3510Abstain
John Hancock38,9860 00For
Voya00 35,5190Abstain
Calvert33,7330 00For
Federated Hermes32,7500 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

3. ELECTION OF DIRECTORS: Demetrios L. Kouzoukas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 1,003,131,251WITHHELD: 11,409,888

Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Demetrios L. Kouzoukas”): 1,003,131,251 for, 11,409,888 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 44 asset managers below cast 100% of the shares they voted on this item FOR (31,384,500 for, 0 against).

FOR 94%
FOR: 31,384,500 (93.8%)ABSTAIN: 2,065,602 (6.2%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Demetrios L. Kouzoukas” at Clover Health Investments, Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,478,8020 37,8790For
Charles Schwab5,306,4210 00For
BlackRock2,548,8260 00For
Fidelity1,175,0870 00For
Equitable832,2930 00For
TIAA00 733,9240Abstain
Lincoln Financial00 526,0540Abstain
Global X335,6780 00For
Northern Trust182,9890 00For
State Street1540 159,6500Abstain
JPMorgan145,4080 00For
Pacific Life138,1830 00For
Lazard00 100,9170Abstain
Dimensional00 79,5730Abstain
Bridge Builder Trust78,3410 00For
SEI60,2000 00For
DWS00 56,9760Abstain
ProShares00 45,5150Abstain
AIG/SunAmerica00 45,3160Abstain
T. Rowe Price00 40,7350Abstain
Jackson National00 39,3510Abstain
John Hancock00 38,9860Abstain
Voya00 35,5190Abstain
Calvert00 33,7330Abstain
Federated Hermes32,7500 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

4. ELECTION OF DIRECTORS: Thomas L. Tran

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 996,918,879WITHHELD: 17,622,260

Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Thomas L. Tran”): 996,918,879 for, 17,622,260 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 44 asset managers below cast 100% of the shares they voted on this item FOR (25,479,280 for, 0 against).

FOR 76%ABSTAIN 24%
FOR: 25,479,280 (76.2%)ABSTAIN: 7,970,822 (23.8%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Thomas L. Tran” at Clover Health Investments, Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,498,1910 18,4900For
Charles Schwab00 5,306,4210Abstain
BlackRock2,548,8260 00For
Fidelity236,8170 938,2700Abstain
Equitable568,3930 263,9000For
TIAA733,9240 00For
Lincoln Financial278,2000 247,8540For
Global X00 335,6780Abstain
Northern Trust00 182,9890Abstain
State Street159,3830 4210For
JPMorgan145,4080 00For
Pacific Life138,1830 00For
Lazard00 100,9170Abstain
Dimensional00 79,5730Abstain
Bridge Builder Trust78,3410 00For
SEI00 60,2000Abstain
DWS00 56,9760Abstain
ProShares00 45,5150Abstain
AIG/SunAmerica00 45,3160Abstain
T. Rowe Price00 40,7350Abstain
Jackson National00 39,3510Abstain
John Hancock00 38,9860Abstain
Voya00 35,5190Abstain
Calvert00 33,7330Abstain
Federated Hermes32,7500 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

5. THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

AUDIT-RELATEDMajority of the votes cast: yes

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 1,188,467,663AGAINST: 2,471,606

Clover Health Investments, Corp.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026”): 1,188,467,663 for, 2,471,606 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 44 asset managers below cast 99.9% of the shares they voted on this item FOR (33,450,094 for, 6 against).

FOR 99.9%
FOR: 33,450,094 (100.0%)AGAINST: 6 (0.0%)ABSTAIN: 3 (0.0%)
Largest asset managers voting on “THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Clover Health Investments, Corp., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,516,6736 30For
Charles Schwab5,306,4210 00For
BlackRock2,548,8260 00For
Fidelity1,175,0870 00For
Equitable832,2930 00For
TIAA733,9240 00For
Lincoln Financial526,0540 00For
Global X335,6780 00For
Northern Trust182,9890 00For
State Street159,8040 00For
JPMorgan145,4080 00For
Pacific Life138,1830 00For
Lazard100,9170 00For
Dimensional79,5730 00For
Bridge Builder Trust78,3410 00For
SEI60,2000 00For
DWS56,9760 00For
ProShares45,5150 00For
AIG/SunAmerica45,3160 00For
T. Rowe Price40,7350 00For
Jackson National39,3510 00For
John Hancock38,9860 00For
Voya35,5190 00For
Calvert33,7330 00For
Federated Hermes32,7500 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Largest Clover Health Investments, Corp. shareholders voting in 2025-2026

Ranked by the number of Clover Health Investments, Corp. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 522,184,385 shares outstanding at the time of that meeting.

Top Clover Health Investments, Corp. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 4.57%
2BlackRock 2.63%
3Charles Schwab 2.03%
4State Street 0.77%
5Northern Trust 0.44%
6GEODE CAPITAL MANAGEMENT, LLC 0.34%
7Fidelity 0.23%
8Equitable 0.16%
9Nuveen 0.16%
10TIAA 0.14%

Reported Clover Health Investments, Corp. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Clover Health Investments, Corp. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Entities affiliated with Vivek Garipalli 16.01% DEF14A
BlackRock 6.10% 13F
Vanguard Group 4.50% 13F
Geode Capital 1.93% 13F
State Street 1.83% 13F
Andrew Toy 1.19% DEF14A
Charles Schwab 1.02% 13F
Dimensional Fund Advisors 0.65% 13F
Renaissance Technologies 0.65% 13F
Citadel Advisors 0.64% 13F

Percentages above are of 522,184,385 shares outstanding, as reported by Clover Health Investments, Corp. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Clover Health Investments, Corp.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Clover Health Investments, Corp.'s shareholder meeting held 2026-06-10, in the 2025-2026 proxy season, 163 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 838 separate fund positions. On the most widely held item on that ballot — Non-binding advisory proposal to approve the compensation paid to our named executive officers… — FOR was 99.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Clover Health Investments, Corp.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-12.

Clover Health Investments, Corp. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).